P2Y12 Inhibitor Monotherapy with Clopidogrel Versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Clopidogrel Pharmacogenetics: State-of-the-Art Review and the TAILOR-PCI Study
Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and ischemic risk. Rationale and design of the OPT-BIRISK double-blinded, placebo-controlled randomized trial
Patient Selection and Clinical Outcomes in the STOPDAPT-2 Trial: An All-Comer Single-Center Registry During the Enrollment Period of the STOPDAPT-2 Randomized Controlled Trial
Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease
Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial
Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet Substudy
Ticagrelor with or without Aspirin in High-Risk Patients after PCI
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.